Global Dry Eye Syndrome Treatment Market

Dry Eye Syndrome Treatment Market Size, Share, Growth Analysis, By Type (Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome), By Drugs (Xiidra, Restasis), By Product, By Dosage Form, By Sales Channel, By Region - Industry Forecast 2026-2033

Report ID: SQMIG35D2131 | Region: Global | Published Date: December, 2025
Pages: 157 |Tables: 65 |Figures: 75

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Dry Eye Syndrome Treatment Market size was valued at USD 7.56 Billion in 2024 and is poised to grow from USD 8.09 Billion in 2025 to USD 13.9 Billion by 2033, growing at a CAGR of 7% during the forecast period (2026–2033).

    The global dry eye syndrome treatment market is characterized by intense competition among key players striving to gain a competitive edge. Established pharmaceutical companies and innovative biotech firms are engaged in continuous research and development to introduce advanced therapies and novel treatment options. Additionally, strategic collaborations, mergers, and acquisitions are prevalent in the market to expand product portfolios and enhance global market presence. Factors such as rising awareness of dry eye syndrome, an aging population, and technological advancements contribute to the market's growth, fostering a highly competitive landscape focused on addressing patient needs effectively. 'Novartis AG (Switzerland) ', 'AbbVie Inc. (USA) ', 'Sun Pharmaceutical Industries Ltd. (India) ', 'Santen Pharmaceutical Co. Ltd. (Japan) ', 'AFT Pharmaceuticals (New Zealand) ', 'Johnson & Johnson Services, Inc. (USA) ', 'Otsuka Pharmaceutical Co. Ltd. (Japan) ', 'OASIS Medical (USA) ', 'Bausch Health Companies Inc. (Canada) ', 'Alcon Inc. (Switzerland) ', 'Akorn Operating Company LLC (USA) ', 'Alimera Sciences (USA) ', 'GlaxoSmithKline plc (UK) ', 'Nicox S.A. (France) ', 'Novaliq GmbH (Germany) ', 'Horus Pharma (France) ', 'Mitotech (Russia) ', 'Prestige Consumer Healthcare (USA) ', 'Sentiss Pharma Pvt. Ltd. (India) ', 'VISUfarma (Netherlands)'

    The growing prevalence of dry eye syndrome (DES) worldwide is a significant driver propelling the growth of the global dry eye syndrome treatment market. Factors such as increasing screen time due to digitalization, aging population, environmental pollution, and lifestyle changes have contributed to a higher incidence of DES. As a result, there is a rising demand for effective and innovative treatment options, including artificial tears, anti-inflammatory medications, and punctal plugs, driving the market's expansion.

    There was a growing preference for preservative-free eye drops and artificial tears due to increased awareness about potential side effects of preservatives.

    North America dominated the market due to high awareness, advanced healthcare infrastructure, and a large patient pool. Europe followed closely, driven by an aging population and increasing prevalence of dry eye cases.

    Related Reports

    Dry Eye Disease Market
    Buy Now GET FREE SAMPLE
    Retinal Disorder Treatment Market
    Buy Now GET FREE SAMPLE
    Ophthalmic Disease Therapeutics Market
    Buy Now GET FREE SAMPLE
    Eye Health Supplements Market
    Buy Now GET FREE SAMPLE
    Eye Health Ingredients Market
    Buy Now GET FREE SAMPLE
    Macular Degeneration Treatment Market
    Buy Now GET FREE SAMPLE
    Retinal Disease Therapeutics Market
    Buy Now GET FREE SAMPLE
    Ophthalmic Drugs Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Dry Eye Syndrome Treatment Market

    Report ID: SQMIG35D2131

    $5,300
    BUY NOW